Troluce Capital Advisors’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
990,472
+617,260
+165% +$9.47M 0.85% 40
2025
Q4
$4.74M Buy
373,212
+326,490
+699% +$4.45M 3.01% 10
2025
Q3
$668K Sell
46,722
-39,069
-46% -$547K 0.09% 36
2025
Q2
$1.05M Sell
85,791
-69,806
-45% -$765K 0.25% 24
2025
Q1
$1.72M Buy
+155,597
New +$1.74M 0.51% 23

Other funds holding GHRS

Troluce Capital Advisors's GHRS Position: Q1 2026 in Review

Troluce Capital Advisors increased its GH Research (GHRS) stake by 165% in Q1 2026, buying an estimated $9.47M and bringing the position to 990,472 shares worth $13.9M. The position accounts for 0.85% of the portfolio, ranked #40.

Troluce Capital Advisors first reported a position in GHRS in Q1 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Troluce Capital Advisors held 990,472 shares of GH Research worth $13.9M as of Q1 2026.
  • Troluce Capital Advisors bought 617,260 GH Research shares in Q1 2026, an estimated $9.47M.
  • GH Research made up 0.85% of Troluce Capital Advisors's portfolio in Q1 2026, its #40 holding.
  • Troluce Capital Advisors first reported a position in GH Research in Q1 2025 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Troluce Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.